Josh Nathan-Kazis
June 20, 2019 10:26 am ET
Analysts
are cheering the long-delayed completion of UnitedHealth Group ’s acquisition of a large physician group from DaVita , another step in the consolidation of the health-care
industry.
A year
and a half after the deal was announced, the Federal Trade Commission on
Wednesday finally cleared the $4.3 billion purchase, on the condition that the
company sell certain clinics in Nevada. The move brings hundreds of clinics and
dozens of urgent-care centers under the mammoth health-insurance company’s
corporate umbrella.
Analysts,
meanwhile, signaled relief. “This seems like a favorable outcome given a very
lengthy FTC review…that raised concerns the FTC might seek to block the entire
deal,” wrote Matt Borsch, an analyst at BMO Equity Research. Borsch kept his Outperform rating
on the stock.
Ana
Gupte at SVB Leerink also
rates the stock Outperform. She wrote that she was “more positive on UNH after
completion of the DaVita deal. We expect the long awaited announcement to be a
positive catalyst for the name.”
The
back story. In December 2017, UnitedHealth Group (ticker: UNH) subsidiary
Optum announced its acquisition of DaVita’s (DVA) physician group, called DaVita
Medical Group, for $4.9 billion, a figure that was later revised down to $4.3
billion. DaVita also operates a large network of dialysis clinics. The
acquisition has been held up in regulatory stasis ever since.
What’s
new. Approval of the acquisition relieves fears that the FTC
would block it altogether.
“We are
excited to take this important step in building a next-generation
comprehensive, coordinated health care organization,” Optum CEO Andrew
Witty said in a statement.
Looking
forward. Cantor Fitzgerald analyst Kyle Mikson reiterated his Overweight rating on
UnitedHealth group after the FTC announcement. “DMG will likely contribute at
least $4 billion in annual revenue (after the divestiture) to the OptumHealth
segment, and there is some overlap with UNH’s insurance businesses in various
markets,” he wrote.
UnitedHealth
shares rose 0.3% to $251.04 early Thursday after gaining 1.8% on Wednesday.
Shares of DaVita were up 3% to $52.81, while the S&P 500
was up 1%.
No comments:
Post a Comment